logo

UK News

Share

pharma-041618.jpg Today's Daily Dose brings you news about Arcus' phase I trial data of AB928; FDA briefing documents related to GW Pharma's Epidiolex; STELLAR results of Novocure and FDA approval of Rigel's ITP drug and Ultragenyx Pharma's X-linked hypophosphatemia drug.

Follow RTT